Relapse Clinical Trials in Sherbrooke, Quebec
3 recruitingSherbrooke, Quebec, Canada
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Marginal Zone LymphomaRelapsed/Refractory Follicular Lymphoma
BeiGene780 enrolled277 locationsNCT05100862
Recruiting
Phase 1Phase 2
IA Carboplatin + Radiotherapy in Relapsing GBM
RelapseGlioblastoma Multiforme
Université de Sherbrooke35 enrolled1 locationNCT03672721
Recruiting
Phase 2
Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
RelapseGlioblastoma Multiforme
Université de Sherbrooke120 enrolled1 locationNCT06356883